Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3. Describe the components of a monitoring plan to assess effectiveness and adverse effects of pharmacotherapy for invasive fungal disease. 4. Evaluate the role of antifungal prophylaxis in the prevention of opportunistic fungal diseases.
Invasive fungal Infections
Lewis RE
Writing – Original Draft Preparation
;
2016
Abstract
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3. Describe the components of a monitoring plan to assess effectiveness and adverse effects of pharmacotherapy for invasive fungal disease. 4. Evaluate the role of antifungal prophylaxis in the prevention of opportunistic fungal diseases.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
